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STUDY DAY
ACPOPC Southern Group Fatigue Study day
Introduction
This study day was held at Forest Holme, Poole, Dorset on Wednesday 14th September 2005 and was
sponsored by Orthobiotech. Speakers included: Caroline Belchamber, Senior 1 Oncology
Physiotherapist, Helen Turnball, clinical Oncology registrar, Dr Richard Osborne,
Consultant Clinical Oncologist, and Caroline Shelton, complementary therapist. All
speakers currently work at Poole hospital NHS Trust, Poole Dorset. Topics included:
pathology of cancer; Fatigue: an overview; the effects of radiotherapy and chemotherapy
on fatigue; relaxation techniques, a practical session involving hand massage. Our
regional representative, Sarah Varman, shared southern regional new with us and local
professional developments were discussed.
Aims of the study day
• To provide a general overview of the causes of fatigue in cancer patients
• To provide a clearer understanding of the treatment options available to manage fatigue
Objectives of the study day
• To have a clearer understanding of the aetiology and pathophysiology of cancer
• To understand the effects of cancer treatments on fatigue
• To be aware of the treatment options available to manage fatigue in cancer patients
• To understand more clearly the different roles that the multi-disciplinary team has in the management of
fatigue in cancer patients
Pathology of cancer
The definition of cancer was discussed as well as its risk factors; environmental,
hereditary (genetic); viral; age which all have a common link – mutations in
Deoxyribonucleic acid (DNA).
A process known as carcinogenesis generates cancers. It is a multi-step mechanism
resulting from accumulation of errors in vital regulatory pathways. The cell cycle is
usually very carefully regulated and subject to internal and external regulatory signals.
Changing proliferation, apoptosis or differentiation can alter growth. Oncogenes are
normal regulatory genes whose activity are increased as a consequence of genetic
alteration and can result in an altered product or increased production of a normal
protein. Ras oncogene is commonly mutated in colon and pancreatic cancers. This
oncogene product is permanently “on”. Tumour suppressor genes on the other hand
code for inhibitory proteins whose function is lost in cancer. Inhibitory proteins that must
be reversibly inactivated for growth to occur restrict normal cell growth and other
functions. Mutations are usually repaired, especially before the cell can go through
mitosis and there is evidence that cancer cells have defective DNA repair mechanisms.
Hence some genetic illnesses with defective DNA repair mechanisms are more at risk
from cancer.
The differences between benign and malignant tumours were also discussed and it was noted that malignant tumours
have the ability to invade and metastasis where as benign tumours do not. Metastasis is the escape of cancer cells
from a primary site and their re-establishment at distant secondary locations. Metastasis requires, disruption of local
cell – cell interactions; invasion and penetration of blood or lymphatic vessels; escape from those vessels
(extravasations); migration; growth. The routes of transport include boy cavities or blood vessels (the anatomy of
blood circulation partly determines the site of metastasis – first pass organ) and the lymphatic vessels (can reach the
blood stream via the superior vena cava). Angiogenesis is important for establishment of primary tumours at their
initial site but is also rate limiting and can therefore determine whether or not a metastasis remains dormant or grows
to a size > 1mm.
Summary
DNA mutations lead to uncontrolled cell proliferation with some cells having the potential
to spread to other parts of the body- metastasis. Symptoms include; local invasion;
disruption of an organ function; electrolyte imbalance; anaemia.
The Effects of Radiotherapy and Chemotherapy on Fatigue
Fatigue in cancer patients is a  complex  multidimensional  and  challenging  problem  for
both patients and the multidisciplinary team.  It is compounded by the  fact  that  currently
there is no one accepted specific biological, physiological or psychological  pathogenesis
identified as the sole causative factor.
There are many factors, which can cause the symptoms of fatigue so a thorough assessment is key to the  management
of this patient group. Assessment should include  a  detailed  history  including  fatigue  pattern,  contributing  factors,
sleep pattern, drug history, psychological profiling, activities of daily living and any other reversible factors.
Factors that cause fatigue are potentially reversible and their  identification  can  influence  the  management  of  these
patients. They  include  disease  treatment,  nutrition  and  psychological  status.  Cancer  therapies  (radiotherapy  and
chemotherapy) affect normal tissues as well as diseased tissue so the  repair  demand  is  greater,  thus  increasing  the
cellular  energy  demand.  Those  patients  who  are  anaemic   need   monitoring   for   transfusions.   Patients   whose
haemoglobin is 10 and above will have more energy. Certain patients are appropriate for EPO to manage this  so  they
don’t need transfusions. If a patient’s nutrition is poor and they are not receiving sufficient nutrients then their  energy
requirements outweigh their intake, which can lead to muscle wasting and fatigue. If  nutrition  and  haemoglobin  are
not addressed there is an  increased  workload  on  the  lungs  due  to  increased  carbon  dioxide,  therefore  decreased
exercise tolerance and reduced energy levels. Dr Osborne encourages high calorie intake, optimising  bowel  function,
and  the  use  of  anti-emetics  to  control  vomiting.   Psychological  factors  such  as  anxiety  and  depression  further
compound things with consistent prolonged anxiety and depression linked to long-term fatigue.
Physiotherapy can recondition patients, although deconditioning occurs quicker. Anxiety and  depression  need  to  be
addressed  before  rehabilitation  can  take  place.  Patients  need  to  be   motivated   and   have   ownership   of   their
rehabilitation programme. This needs to be a continuous process adjusted to their disease  progression.  Rehabilitation
programmes can increase exercise tolerance and raise endorphin levels thus enhancing mood. Improved  outcomes  in
cancer patients who regularly exercise has been supported by a recent studies including Blanchard  et  al  2001  where
anxiety was reduced through exercise and Porock et al 2000 study showed that exercise relieved fatigue and enhanced
energy. However neither of these studies was able to isolate the mechanism (s) by which fatigue was relieved.
Complementary therapy
Patients  in  the  Dorset  Cancer  Centre  have  access  to  a  range  of  complementary  therapy   techniques   including
aromatherapy, reflexology and support classes.  Complementary  therapy  can  help  relieve  stress  and  anxiety,  thus
reducing symptoms of fatigue. Aromatherapy oils help the body recover from fatigue, rather than masking its  effects.
The therapists access patients on the wards and in day care commonly applying aromatherapy to hands and  feet.  Oils
that are particularly effective include; bergamont, grapefruit, geranium, with  rosemary  especially  recommended  for
mental fatigue. 
Local Developments
Closure of a local palliative care unit was discussed, which raised debate about the future job security in the  palliative
care setting. Is palliative care support seen as an additional extra and not essential in today’s health care agenda?
Spinal Cord  Compression  was  discussed  at  length  and  Poole  Hospital  are  currently  developing  a  pathway  and
physiotherapy protocol for the management of this patient group. Issues arising included spinal stability and  the  lack
of consensus regarding timing of the mobilisation of patients.
A  concern  raised  was  the  link  between  autonomic  dysreflexia  and  spinal  cord  compression,  should  the   same
precautionary measures used with spinal cord injuries be transferred to this patient group?
Next meeting – Southampton General Hospital – Topic to be arranged.
Summary
Fatigue is a complex multifactorial problem. Identification of the reversible and contributory factors can decrease  the
symptoms of  fatigue.  More  research  and  increased  Multi-disciplinary  Team  working  in  this  complex  area  will
enhance patients’ quality of life.
Conclusion
Twenty delegates attended  the  study  day  and  the  feedback  was  very  positive.  One
hundred percent agreed that their knowledge of cancer, cancer treatment and their effect
on fatigue had increased following the study day as  well  as  their  knowledge  of  fatigue
management in cancer patients. Everyone thought that the practical session was a useful
adjunct to the presentations. Overall the study day was rated as either excellent or good.
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